The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $136.45

Today's change-1.08 -0.79%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $136.45

Today's change-1.08 -0.79%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc down (U.S.)$1.08

USANA Health Sciences Inc closed lower Friday, dropping (U.S.)$1.08 or 0.79% to (U.S.)$136.45. Over the last five days, shares have gained 2.19% and 6.81% year to date. Shares have underperformed the S&P 500 by 19.74% during the last year.

Key company metrics

  • Open(U.S.) $137.21
  • Previous close(U.S.) $137.53
  • High(U.S.) $137.47
  • Low(U.S.) $135.38
  • Bid / Ask-- / --
  • YTD % change+6.81%
  • Volume112,189
  • Average volume (10-day)109,829
  • Average volume (1-month)118,010
  • Average volume (3-month)107,208
  • 52-week range(U.S.) $92.00 to (U.S.) $151.18
  • Beta1.16
  • Trailing P/E17.97×
  • P/E 1 year forward16.78×
  • Forward PEG1.68×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.59
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.12%

Based on its net profit margin of 10.12%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.06%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 02, 201607/02/2016Apr 02, 201604/02/2016Jan 02, 201601/02/2016Oct 03, 201510/03/2015
Revenue259240233233
Total other revenue--------
Total revenue259240233233
Gross profit213198192192
Total cost of revenue46434041
Total operating expense221207197195
Selling / general / administrative175164157154
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income37343538
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax38333638
Income after tax26222426
Income tax, total12111213
Net income26222426
Total adjustments to net income--------
Net income before extra. items26222426
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items26222426
Inc. avail. to common incl. extra. items26222426
Diluted net income26222426
Dilution adjustment--------
Diluted weighted average shares12131313
Diluted EPS excluding extraordinary itemsvalue per share2.071.771.831.92
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share2.071.771.831.92